THIRD NATIONAL REGISTRY OF ACUTE CORONARY SYNDROMES
RENASICA_III
1 other identifier
observational
8,296
0 countries
N/A
Brief Summary
The Registry pretends to identify stratification, diagnosis and treatment approaches in patients with Acute Coronary Syndrome (ACS) in community hospitals with tertiary hospitals to optimize resources and identify strategies to improve health care quality through the creation of clinical guidelines that serve for unify management and treatment methods with adherence to international guidelines which include suggestions for treatment and medication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2012
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 15, 2014
CompletedFirst Posted
Study publicly available on registry
May 19, 2014
CompletedMay 19, 2014
May 1, 2014
8 months
May 15, 2014
May 15, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patients with complications after presenting ACS
The main objective will be to know the evolution of ACS in third and second level hospitals with a monitoring at a minimum of one year for each patient.
up to one year
Eligibility Criteria
It will include patients older than 18 years with ACS final diagnosis and objective evidence of atherosclerotic coronary disease. Patients will be identified in the emergency department, coronary care units, intensive care units, hospital and hemodynamic laboratories
You may qualify if:
- all patients with suspected ACS and will analyze risk factors, chest pain and electrocardiographic characteristics.
You may not qualify if:
- Patients with secondary ischemia (anaemia, pulmonary thromboembolism, myocarditis) and type II infarction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2014
First Posted
May 19, 2014
Study Start
November 1, 2012
Primary Completion
July 1, 2013
Study Completion
November 1, 2013
Last Updated
May 19, 2014
Record last verified: 2014-05